It's the keys to unlocking major shareholder value. I'm not sure what capex was needed for Oxley - considering if it went smaller scale start up then expanded.
First Oxley -
"Start-up high value potassium nitrate fertiliser operation being considered in Prefeasibility Study along with future expansion into bulk potassium fertilisers
Engineering reviews to determine the go-forward option for the Prefeasibility Study progressed during the quarter for Oxley. The Prefeasibility Study is based on a start-up high value potassium nitrate fertiliser operation with consideration of future expansion into other bulk potassium fertilisers"
But now with Admore - DSO operations are typically low Capex - would generate cash for the capex of Oxley .
What margin on $110/t rock phosphate ?
At surface ?
The key here is look ahead to what how dilution will be minimised - compared with hundreds of million in revenue PA and capex funded by Admore cash flow and probably debt. It's a big prize and the pendulum is swinging with credibility to unlock it. .
- Forums
- ASX - By Stock
- CXM
- Cash backed and a major Potash resource
CXM
centrex limited
Add to My Watchlist
0.00%
!
1.7¢

Cash backed and a major Potash resource, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.74M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CXM (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online